Patients undergoing radiation therapy for the head and neck are susceptible to a significant
and often abrupt deterioration in their oral health. The oral morbidities of radiation therapy …

BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Oral mucositis is a common complication of cancer treatment that may negatively impact the
patient's cancer treatment outcome. Despite its frequency and consequences, the lack of …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

Oral mucositis (OM) is a major limiting acute side effect of radiotherapy for head and neck
cancer. The spectrum of problems associated with mucositis includes oral pain …

An estimated 1.6 million people receive cancer therapy in the United States each year and
worldwide numbers are much higher. 1 Although advancements in cancer therapy improved …

Background Oral mucositis (OM) due to radiotherapy and systemic therapies in head and
neck cancer treatment represents a major problem causing a wide spectrum of clinical signs …

Purpose The aim of this systematic review was to update the clinical practice guidelines for
the use of anti-inflammatory agents in the prevention and/or treatment of oral mucositis …

Purpose To update the 2015 clinical practice guideline for the prevention of oral mucositis in
pediatric cancer or hematopoietic stem cell transplant (HSCT) patients. Methods We …

Purpose To develop an evidence-based clinical practice guideline for the prevention of oral
mucositis in children (0–18 years) receiving treatment for cancer or undergoing …